Answers are grounded in this paper and cite their sources.
Topiramate (TOP) is a novel anticonvulsant drug with multiple mechanisms of action used in the treatment of epilepsy. Measurements of cerebral GABA were obtained in six controls using 1H MRS at baseline and at 3 and 6 hours following the administration of 3 mg/kg of TOP. Brain GABA concentrations rose by 72% at 3 hours and by 64% at 6 hours compared with baseline (p < 0.004). This study demonstrates that TOP significantly increases human cerebral GABA concentrations in healthy individuals.
No takes yet. Share an insight, caveat, or question.
Kuzniecky et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: